---
ID: "9373b055-01be-4f05-9298-7752a35a8e8b"
Parent: "f6944cae-c718-41cd-b820-d49ce2ed7d27"
Template: "ab8309b9-e012-4c89-88bb-6d364fb5e0db"
Path: /sitecore/content/LionTrustNew/Home/Insights/Monthly Comms/2019/08/Liontrust GF UK Growth Fund July 2019 review
DB: master
SharedFields:
- ID: "ba3f86a2-4a1c-4d78-b63d-91c2779c1b5e"
  Hint: __Sortorder
  Value: 31100
Languages:
- Language: en
  Versions:
  - Version: 1
    Fields:
    - ID: "094932b9-ff77-4977-966e-d18f7c7ac091"
      Hint: LegacyArticle_Subtitle
      Value: July 2019 review
    - ID: "199ae724-078d-49b4-9e50-03f4c5e9e938"
      Hint: LegacyPresentationBase_BrowserTitle
      Value: Liontrust GF UK Growth Fund July 2019 review | What we think | Liontrust Asset Management PLC
    - ID: "1c19356a-6e47-4d77-ba56-ade349f17b9d"
      Hint: LegacyArticle_Title
      Value: Liontrust GF UK Growth Fund 
    - ID: "25bed78c-4957-4165-998a-ca1b52f67497"
      Hint: __Created
      Value: 20190812T172826Z
    - ID: "52161005-9691-46cd-af73-e2b5455474c0"
      Hint: LegacyArticle_Fund
      Value: "{2335DB68-AD95-4E4E-B11B-007605557258}"
    - ID: "58b0791b-504e-423c-8d9e-e16c419353fa"
      Hint: LegacyArticle_BlogType
      Value: "{D0700E76-8BC2-427A-9849-FE3B6D28BD22}"
    - ID: "5dd74568-4d4b-44c1-b513-0af5f4cda34f"
      Hint: __Created by
      Value: |
        sitecore\jackh
    - ID: "6febf0b3-6bdb-43ea-9041-ca30ca342bb3"
      Hint: LegacyPresentationBase_SubNavigationMenu
      Value: "{4D8848D7-ABC1-4206-A6A9-21B174B7E945}"
    - ID: "8a3692c4-8014-4bdd-9f9f-74acfcc1c501"
      Hint: LegacyPresentationBase_ShortDescription
      Value: Bounce in Indivior and strong results from pharma holdings GlaxoSmithKline and AstraZeneca boost Fund, although slightly behind index for the month.
    - ID: "aebdd235-46dd-490a-bae3-c613c670a8bf"
      Hint: LegacyPresentationBase_PageTitle
      Value: Liontrust GF UK Growth Fund July 2019 review
